Does Availability of Fetal Fibronectin Testing in the Management of Threatened Preterm Labour Affect the Utilization of Hospital Resources?

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 7, 2005, Pages 689-694

  Abenhaim, Haim A ^a   Morin, Lucie ^a   Benjamin, Alice ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cost analysis; Fetal fibronectin; Hospital admission; Preterm labour

Indexed keywords

FIBRONECTIN; FFN PROTEIN, HUMAN; GLYCOPROTEIN;

ARTICLE; COST CONTROL; FEMALE; FETAL FIBRONECTIN TESTING; FETUS FUNCTION TEST; GESTATIONAL AGE; HOSPITAL COST; HOSPITAL UTILIZATION; HUMAN; LENGTH OF STAY; PREMATURE LABOR; QUEBEC; TEACHING HOSPITAL; ADULT; COHORT ANALYSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HOSPITALIZATION; PREGNANCY; PROSPECTIVE STUDY;

ADULT; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROSPECTIVE STUDIES;

EID: 26944478202     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30547-3     Document Type: Article

References (17)

1. McCormic MC The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985, 312:82-90.
2. Hack M, Fanaroff AA Outcomes of extremely immature infants-a perinatal dilemma. N Engl J Med 1993, 329:1649-1650.
3. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999, 94:869-877.
4. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med 1992, 327:308-312.
5. Lockwood CJ, Senyei AE, Dische R Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991, 325:669-674.
6. Feinberg RF, Klnnan HJ, Lockwood CJ Is oncofetal fibronectin a trophoblast glue for implantation?. Am J Pathol 1991, 138:537-543.
7. Matsuura H, Hakomori S The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectin from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Nat Acad Sci USA 1985, 82:6517-6521.
8. Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999, 180:581-586.
9. Chien PF, Khan KS, Ogston S, Owen P Diagnostic accuracy of cervicovaginal fetal fibronectin in predicting preterm labour: an overview. Br J Obstet Gynecol 1997, 104:436-444.
10. Ascarelli MH, Morrison JC Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997, 52:S1-S2.
11. Iams JD, Casal D, McGregor JA Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995, 173:141-145.
12. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997, 177:13-18.
13. Nageotte MP, Casal D, Senyei AE Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994, 173:20-25.
14. Sullivan A, Hueppchen NA, Satin AJ Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm. J Matern Fetal Med 2001, 10:380-384.
15. Oliveira T, de Souza E, Mariani-Neto C, Camano L Fetal fibronectin as a predictor of preterm delivery in twin gestations. Int J Gynaecol Obstet 1998, 62:135-139.
16. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1996, 75:1047-1053.
17. lams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996, 334:567-572.